Sleep Disorder Ctr-Lehigh Vly is categorized under Doctors in Bethlehem, PA .
Sleep Disorder Ctr-Lehigh Vly was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Denise Schuler, Office Manager at the company’s single location by writing to 2545 Schoenersville Road, Bethlehem, Pennsylvania PA 18017 or by phoning (484) 884-8030. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sleep Disorder Ctr-Lehigh Vly |
| Contact Person: | Denise Schuler, Office Manager |
| Address: | 2545 Schoenersville Road, Bethlehem, Pennsylvania 18017 |
| Phone Number: | (484) 884-8030 |
| Website Address: | lvh.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Sleep Disorder Ctr-Lehigh Vly was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Denise Schuler, Office Manager for inquiries that concern Sleep Disorder Ctr-Lehigh Vly by calling the company number (484) 884-8030, as your correspondence is most welcome. Additionally, the physical location of the single location of Sleep Disorder Ctr-Lehigh Vly can be found at the coordinates 40.64611,-75.40671 as well as the street address 2545 Schoenersville Road in Bethlehem, Pennsylvania 18017.
For its online presence, you may visit Sleep Disorder Ctr-Lehigh Vly’s website at lvh.com and engage with its social media outlets through on Twitter and on Facebook.